Patents by Inventor Wu Yang

Wu Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND APPARATUS FOR AUTOMATICALLY DISCOVERING GAS STATION POI, STORAGE MEDIUM AND DEVICE
    Publication number: 20180285371
    Abstract: Embodiments of the present disclosure disclose a method and apparatus for automatically discovering a gas station point of interest (POI), a storage medium and a device, wherein, the method includes: collecting information uploaded by an on-board diagnostic (OBD) device, and determining gasoline quantity surge points based on the information; clustering the gasoline quantity surge points based on location information by using a clustering algorithm; and determining a location region having the gas station POI based on a result of clustering. The technical schemes provided by the embodiments of the present disclosure are capable of automatically determining the location region having the gas station POI, thereby reducing collection cost of gas station POI information and shortening an updating period for gas station POIs.
    Type: Application
    Filed: December 16, 2015
    Publication date: October 4, 2018
    Inventors: Long GAO, Shangwei JIAO, Yu ZHI, Wu YANG, Guanyang CAI, Xin ZHANG, Zenggang LIU
  • ELECTRONIC DEVICE AND METHOD FOR CONTROLLING FAN OPERATION
    Publication number: 20180228050
    Abstract: An electronic device and a method for controlling a fan operation are provided. A containing space of the electronic device has a fan module and a deformation sensor. The deformation sensor detects whether a fan housing of the fan module is deformed. The deformation sensor transmits a deformation signal to a controller when detecting that the fan housing is deformed. The controller drives a fan blade of the fan module to stop running after receiving the deformation signal.
    Type: Application
    Filed: December 27, 2017
    Publication date: August 9, 2018
    Applicant: COMPAL ELECTRONICS, INC.
    Inventors: Chih-Chin Chien, I-Feng Hsu, Ching-Chung Chen, Tse-Yang Lin, Tse-An Chu, Ching-Ya Tu, Chang-Yuan Wu, Hao-Wu Yang, Huan-Yang Yeh, Chin-Hsien Chang, Chin-Yuan Chuang, Chia-Hung Lin
  • MACROCYCLIC FACTOR XIA INHIBITORS BEARING HETEROCYCLIC GROUPS
    Publication number: 20180222907
    Abstract: The present invention provides compounds of Formula (Ia): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: April 6, 2018
    Publication date: August 9, 2018
    Inventors: Andrew K. Dilger, James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J.P. Pinto, Michael J. Orwat, Leon M. Smith, II
  • ADAPTIVE PROCESSING OF RADIO FREQUENCY IDENTIFICATION
    Publication number: 20180204031
    Abstract: Embodiments of the present disclosure relate to adaptive RFID communication. A tag device includes a storage configured to store content that is executable by a proxy device associated with a reader device. The tag device includes a communication component configured to transmit the content to the reader device, the content, when executed by the proxy device, causing an action associated with the tag device to be performed.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Inventors: Liang He, Zhen Duo Liu, Chun Lei Xu, Geng Wu Yang, Feng Zheng
  • PYRIMIDINONES AS FACTOR XIA INHIBITORS
    Publication number: 20180186795
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 5, 2018
    Inventors: Andrew K. Dilger, James R. Corte, lndawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J.P. Pinto, Michael J. Orwat, Leon M. Smith, II
  • Adaptive processing of radio frequency identification
    Patent number: 10002270
    Abstract: Embodiments of the present disclosure relate to adaptive RFID communication. A tag device includes a storage configured to store content that is executable by a proxy device associated with a reader device. The tag device includes a communication component configured to transmit the content to the reader device, the content, when executed by the proxy device, causing an action associated with the tag device to be performed.
    Type: Grant
    Filed: July 28, 2017
    Date of Patent: June 19, 2018
    Assignee: International Business Machines Corporation
    Inventors: Liang He, Zhen Duo Liu, Chun Lei Xu, Geng Wu Yang, Feng Zheng
  • FACTOR XIA MACROCYCLES WITH NOVEL P1 GROUPS
    Publication number: 20180162821
    Abstract: The present invention provides compounds of Formula (I): P-Ma ??(I) or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: December 11, 2017
    Publication date: June 14, 2018
    Inventors: James R. Corte, Andrew K. Dilger, William R. Ewing, Donald J.P. Pinto, Wu Yang
  • NOVEL MACROCYCLES AS FACTOR XIA INHIBITORS
    Publication number: 20180148461
    Abstract: The present invention provides compounds of Formula (Ia): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: January 25, 2018
    Publication date: May 31, 2018
    Inventors: Donald J.P. Pinto, James R. Corte, Wu Yang, William R. Ewing
  • Structure and manufacturing process for unmanned aerial vehicle
    Patent number: 9963229
    Abstract: An unmanned aerial vehicle (UAV) device and the manufacturing process to make the UAV. The UAV device comprises a monocoque shell with a single-piece molded construction that includes a central body and arms that extend outward from the central body. Each of the arms includes a terminal end that is spaced away from the central body. The monocoque shell has a cupped shape with a closed first side and an open second side that includes sidewalls that extend around an interior space. The UAV device comprises a plurality of motors and rotors attached to the first side of the monocoque shell with one of said plurality of motors and rotors positioned at the terminal end of each of the arms.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: May 8, 2018
    Assignee: IDENTIFIED TECHNOLOGIES CORPORATION
    Inventors: Bennett Logan Montooth Welker, Richard Yang Zhang, Anna Wu Yang, Andy Wu
  • Methods and systems for patching direct-mode talkgroups among dual-watch mobile radios
    Patent number: 9961703
    Abstract: Disclosed herein are methods and systems for patching direct-mode talkgroups among dual-watch mobile radios. A mobile radio has first and second receivers, and is in a first talkgroup having a first channel. The mobile radio resides the first receiver on the first channel, and detects either a first patch event or a second patch event. The first patch event is an instruction for a first-channel session. The second patch event is an invitation for a second-channel session. Upon detecting the first patch event, the mobile radio transmits an invitation on the first channel and also on one or more other channels respectively associated with one or more other talkgroups, directing all recipients to the first channel. If the mobile radio detects the second patch event, the mobile radio resides the second receiver on the second channel.
    Type: Grant
    Filed: December 24, 2014
    Date of Patent: May 1, 2018
    Assignee: MOTOROLA SOLUTIONS, INC.
    Inventors: Kang-Kai Zhao, Da-Jun Chen, Ya-Hui Gong, Yi Tang, Yong Tian, Wu Yang, Dong Zhao
  • Dihydropyridone P1 as factor XIa inhibitors
    Patent number: 9951071
    Abstract: The present invention provides compounds of Formula (V): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: April 24, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Wu Yang, James R. Corte, Paul J. Gilligan, Donald J. P. Pinto, William R. Ewing, Andrew K. Dilger, Yufeng Wang, Tianan Fang, Kumar B. Pabbisetty, Leon M. Smith, II
  • Adaptive processing of radio frequency identification
    Patent number: 9946905
    Abstract: Embodiments of the present disclosure relate to adaptive RFID communication. A tag device includes a storage configured to store content that is executable by a proxy device associated with a reader device. The tag device includes a communication component configured to transmit the content to the reader device, the content, when executed by the proxy device, causing an action associated with the tag device to be performed.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: April 17, 2018
    Assignee: International Business Machines Corporation
    Inventors: Liang He, Zhen Duo Liu, Chun Lei Xu, Geng Wu Yang, Feng Zheng
  • Macrocycles as factor XIa inhibitors
    Patent number: 9902742
    Abstract: The present invention provides compounds of Formula (Ia): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: February 27, 2018
    Assignee: Bristol-Myers Squibb Company
    Inventors: Donald J. P. Pinto, James R. Corte, Paul J. Gilligan, Tianan Fang, Leon M. Smith, II, Yufeng Wang, Wu Yang, William R. Ewing
  • MACROCYCLES AS FACTOR XIA INHIBITORS
    Publication number: 20180022753
    Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: September 28, 2017
    Publication date: January 25, 2018
    Inventors: James R. Corte, Tianan Fang, Carl P. Decicco, Donald J.P. Pinto, Karen A. Rossi, Zilun Hu, Yoon Jeon, Mimi L. Quan, Joanne M. Smallheer, Yufeng Wang, Wu Yang
  • MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES
    Publication number: 20170342071
    Abstract: The present invention provides compounds of Formula (Ia): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Application
    Filed: August 18, 2017
    Publication date: November 30, 2017
    Inventors: Andrew K. Dilger, James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J.P. Pinto, Michael J. Orwat, Leon M. Smith, II
  • ADAPTIVE PROCESSING OF RADIO FREQUENCY IDENTIFICATION
    Publication number: 20170323127
    Abstract: Embodiments of the present disclosure relate to adaptive RFID communication. A tag device includes a storage configured to store content that is executable by a proxy device associated with a reader device. The tag device includes a communication component configured to transmit the content to the reader device, the content, when executed by the proxy device, causing an action associated with the tag device to be performed.
    Type: Application
    Filed: July 28, 2017
    Publication date: November 9, 2017
    Inventors: Liang He, Zhen Duo Liu, Chun Lei Xu, Geng Wu Yang, Feng Zheng
  • Macrocycles as factor XIa inhibitors
    Patent number: 9802939
    Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are selective Factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: December 22, 2014
    Date of Patent: October 31, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: James R. Corte, Tianan Fang, Carl P. Decicco, Donald J. P. Pinto, Karen A. Rossi, Zilun Hu, Yoon Jeon, Mimi L. Quan, Joanne M. Smallheer, Yufeng Wang, Wu Yang
  • METHODS AND SYSTEMS FOR PATCHING DIRECT-MODE TALKGROUPS AMONG DUAL-WATCH MOBILE RADIOS
    Publication number: 20170303318
    Abstract: Disclosed herein are methods and systems for patching direct-mode talkgroups among dual-watch mobile radios. A mobile radio has first and second receivers, and is in a first talkgroup having a first channel. The mobile radio resides the first receiver on the first channel, and detects either a first patch event or a second patch event. The first patch event is an instruction for a first-channel session. The second patch event is an invitation for a second-channel session. Upon detecting the first patch event, the mobile radio transmits an invitation on the first channel and also on one or more other channels respectively associated with one or more other talkgroups, directing all recipients to the first channel. If the mobile radio detects the second patch event, the mobile radio resides the second receiver on the second channel.
    Type: Application
    Filed: December 24, 2014
    Publication date: October 19, 2017
    Inventors: KANG-KAI ZHAO, DA-JUN CHEN, YA-HUI GONG, YI TANG, YONG TIAN, WU YANG, DONG ZHAO
  • IMPROVED APPARATUS AND METHOD FOR TRACKING SHORT MESSAGES OF TALK GROUP MEMBERS
    Publication number: 20170290032
    Abstract: A subscriber device joins a talk group and receives, via a control channel, parameters defining a plurality of assigned downlink data transmission periods associated with the talk group on a downlink short data channel. The subscriber device determines from the parameters when a next downlink short data transmission for devices in the talk group will be transmitted on the downlink short data channel. The subscriber device switches to the downlink short data channel during the next transmission period.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 5, 2017
    Inventors: KANG-KAI ZHAO, DA-JUN CHEN, YONG LI, YONG TIAN, WU YANG
  • Macrocycles with aromatic P2? groups as factor xia inhibitors
    Patent number: 9777001
    Abstract: The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    Type: Grant
    Filed: January 30, 2015
    Date of Patent: October 3, 2017
    Assignee: Bristol-Myers Squibb Company
    Inventors: James R. Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Yufeng Wang, Andrew K. Dilger, Kumar Balashanmuga Pabbisetty, William R. Ewing, Yeheng Zhu, Ruth R. Wexler, Donald J. P. Pinto, Michael J. Orwat, Leon M. Smith, II